Investment Summary |
|
|---|---|
| Date | 2003-10-02 |
| Target | Gala Biotech |
| Sector | Life Science |
| Sellers(s) |
Mason Wells
Advantage Capital Partners |
| Deal Type | Trade Sale - Public Company |
| Deal Value | 16M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 600M USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Mason Wells is a private equity firm focused on middle-market buyout opportunities in the Midwest US. Mason Wells looks to invest in businesses operating in engineered products and services, outsourced business services, and specialty packaging. Target companies typically generate revenue of $25 to $300 million and EBITDA of at least $5 million. The Firm prefers businesses with high barriers to entry, limited customer concentration, and strong market positions. Mason Wells was originally formed 1982 as a subsidiary of Marshall & Ilsley Corporation and became an independent firm in 1998. Mason Wells is based in Milwaukee, Wisconsin.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 39 |
| Sector (Life Science) | 1 of 1 |
| Type (Trade Sale - Public Company) | 2 of 11 |
| State (Wisconsin) | 8 of 21 |
| Country (United States) | 9 of 37 |
| Year (2003) | 2 of 2 |
| Size (of disclosed) | 5 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-07-02 |
Eder Industries
Oak Creek, Wisconsin, United States Eder Industries is a Electronic Manufacturing Services (EMS), focused on manufacturing complex electronic assemblies for Original Equipment Manufacturers (OEM’s). |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-12-01 |
ZyStor Therapeutics
Milwaukee, Wisconsin, United States ZyStor Therapeutics, Inc. is a biotechnology company developing innovative therapeutics that will significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs). ZyStor employs a novel, proprietary technology which improves the delivery of therapeutics that replace the missing lysosomal enzyme in LSD patients. ZyStor has demonstrated in cell culture and in a well-characterized animal model that this technology provides several distinct advantages over other LSD therapeutics in use today. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1992 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Agnostic |
Advantage Capital Partners is a private equity firm focused on providing growth capital to a variety of companies. The Firm's geographic coverage includes Alabama, Colorado, Florida, Hawaii, Louisiana, Mississippi, Missouri, New York, Texas, Wisconsin and Washington DC. Advantage looks to initially commit $0.5 to $2 million per investment and can provide mezzanine debt in addition to equity capital. Areas of interest include communications, information technology, life science, and energy. Advantage Capital was formed in 1992 and is headquartered in New Orleans, Louisiana.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 94 |
| Sector (Life Science) | 1 of 6 |
| Type (Trade Sale - Public Company) | 3 of 13 |
| State (Wisconsin) | 1 of 6 |
| Country (United States) | 5 of 94 |
| Year (2003) | 1 of 1 |
| Size (of disclosed) | 10 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-06-01 |
Emageon
Birmingham,, Alabama, United States Emageon, Inc. provides information technology systems for hospitals, healthcare networks, and imaging facilities in the United States. The company offers IT solutions to manage medical image storage and distribution, provider radiology, cardiology and visualization, and manage workflow and medical content management. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-10-08 |
Monarch Machine Tool
Cortland, New York, United States Monarch Machine Tool is a provider of electronic machines intended to offer metal-cutting equipment. Monarch Machine Tool was established in 1909 and is based in Cortland, New York. |
Buy | $4M |
